NEW YORK, Oct. 31, 2023 /PRNewswire/ — The next-generation sequencing market size is forecast to increase by USD 3,409.76 million from 2022 to 2027, at a CAGR of 12.45%, according to the recent market study by Technavio. The growth of the market will be driven by the Increased utilization of NGS methods, Growing demand for early diagnosis of genetic disorders, and Availability of a wide range of NGS products. Technavio has extensively analyzed 15 major vendors, including 10X Genomics Inc., Azenta Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Konica Minolta Inc., Laboratory Corp. of America Holdings, Merck KGaA, Nabsys Inc., OPKO Health Inc., Oxford Nanopore Technologies plc, Perkin Elmer Inc., PierianDx Inc., Psomagen Inc., QIAGEN NV, Standard BioTools Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc. Charts & data tables about market and segment sizes for a historic period of five (2017-2021) years have been covered in this report. Download The Sample Report
Technavio has announced its latest market research report titled Global Next Generation Sequencing Market 2023-2027
Key Benefits for Industry Players and Stakeholders –
The report offers information on the criticality of vendor inputs, including R&D, CAPEX, and technology.
It also provides detailed analyses of the market’s competitive landscape and vendors’ product offerings.
The report also provides a qualitative and quantitative analysis of vendors to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
Expand operations in the future – To get requisite details, ask for a custom report.
Get a holistic overview of the next-generation sequencing market from industry experts to evaluate and develop growth strategies. Download the Sample
Next Generation Sequencing Market – Segmentation Assessment
The market is segmented by end-user (academic research, clinical research, pharma & biotech companies, and others), product (consumables and equipment), and geography (North America, Europe, Asia, and the Rest of the World (ROW))
The market share growth by the academic research segment will be significant during the forecast period. Academic research institutions come under the end-users segment and it includes universities and research institutions, which are major users of NGS technologies for various applications. Furthermore, various tasks such as basic research, drug discovery, personalized medicine, and clinical diagnostics are done by academic researchers using NGS technology. The declining cost of sequencing, the availability of easy-to-use software and analytical tools, and the growing demand for personalized and precision medicine are some of the key factors driving the adoption of NGS technology in segment growth. Hence, these factors are expected to drive market growth during the forecast period.
To get detailed insights about inclusions and exclusions, buy the report
Next Generation Sequencing Market – Market Dynamics
Key Drivers
The increased utilization of NGS methods is a key factor driving market growth.
This growth is due to the various benefits it offers, such as reduction of cost in the performance of sequential studies, providing high processing speed, and can generate a vast number of sequences with many applications in research.
Furthermore, many vendors are offering reliable genetic testing services and products using NGS in the market.
The rising popularity of NGS techniques to detect viral genome sequencing, which includes sequencing of new influenza viruses, detection of viral genome variability, and monitoring of low-abundance antiviral drug-resistance mutations, is increasing the demand.
Hence, these factors are expected to drive market growth during the forecast period.
Major Trends
The reduced costs of gene sequencing are major trends in the market.
This is due to the advances in gene sequencing techniques which also reduce the time taken for the testing procedures.
As a result, the vendors can provide access to more people with limited budgets and overcome the challenge of unaffordable prices.
Furthermore, there are considerable improvements in accuracy due to the adoption of NGS and fluorescence-based fully automated sequencing technologies.
Hence, the affordable prices of these services is expected to boost the growth of the market during the forecast period.
Significant Challenges
The lack of clinical validation on direct-to-consumer genetic tests is a key factor restricting the market growth.
There have been rising questions about the clinical validity of genetic tests sold directly to consumers, which impacts the commercialization of pre-disposition tests.
Furthermore, it is very difficult for consumers to interpret the structural variation in their genes due to the complexity of the results.
These tests have limited accuracy and can often generate false-positive or false-negative results, which harms the mental health of the patients.
Hence, the above-mentioned factors are expected to restrict the growth of the market during the forecast period.
What are the key data covered in this Next Generation Sequencing Market report?
CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the next-generation sequencing market between 2023 and 2027
Precise estimation of the size of the next-generation sequencing market and its contribution to the market with a focus on the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the next-generation sequencing market across North America, Europe, Asia, and the Rest of the World (ROW)
A thorough analysis of the market’s competitive landscape and detailed information about vendors
Comprehensive analysis of factors that will challenge the growth of next-generation sequencing market vendors
Gain instant access to 17,000+ market research reports.
Technavio’s SUBSCRIPTION platform
Related Reports
The vitamin D testing market size is estimated to grow by USD 193.53 million at a CAGR of 5.44% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by product (25-hydroxyvitamin D testing and 1 25-dihydroxy vitamin D testing), end-user (diagnostic laboratories, hospitals, physician clinics, and home care settings), and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The growing prevalence of vitamin D deficiency-related disorders is a key factor driving the market growth during the forecast period.
The oncology molecular diagnostics market size is estimated to grow by USD 2,980.87 million at a CAGR of 11.82% between 2022 and 2027. Furthermore, this report extensively covers market segmentation by type (breast cancer, colorectal cancer, prostate cancer, liver cancer, and others), product (reagents, kits, and instruments), and geography (North America, Europe, Asia, and Rest of the World (ROW)). The increasing prevalence of cancer worldwide is a key factor driving the market growth during the forecast period.
|
Next Generation Sequencing Market Scope |
|
|
Report Coverage |
Details |
|
Base year |
2022 |
|
Historic period |
2017-2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 12.45% |
|
Market growth 2023-2027 |
USD 3,409.76 million |
|
Market structure |
Fragmented |
|
YoY growth 2022-2023 (%) |
11.55 |
|
Regional analysis |
North America, Europe, Asia, and the Rest of the World (ROW) |
|
Performing market contribution |
North America at 38% |
|
Key countries |
US, Canada, Germany, UK, and China |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
10X Genomics Inc., Azenta Inc., BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., Konica Minolta Inc., Laboratory Corp. of America Holdings, Merck KGaA, Nabsys Inc., OPKO Health Inc., Oxford Nanopore Technologies plc, Perkin Elmer Inc., PierianDx Inc., Psomagen Inc., QIAGEN NV, Standard BioTools Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents
1 Executive Summary
1.1 Market Overview
Exhibit 01: Executive Summary – Chart on Market Overview
Exhibit 02: Executive Summary – Data Table on Market Overview
Exhibit 03: Executive Summary – Chart on Global Market Characteristics
Exhibit 04: Executive Summary – Chart on Market by Geography
Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
Exhibit 07: Executive Summary – Chart on Incremental Growth
Exhibit 08: Executive Summary – Data Table on Incremental Growth
Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global – Market size and forecast 2022-2027 (USD million)
Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 (USD million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global next generation sequencing market 2017 – 2021
Exhibit 18: Historic Market Size – Data Table on global next generation sequencing market 2017 – 2021 (USD million)
4.2 End-user Segment Analysis 2017 – 2021
Exhibit 19: Historic Market Size – End-user Segment 2017 – 2021 (USD million)
4.3 Product Segment Analysis 2017 – 2021
Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 (USD million)
4.4 Geography Segment Analysis 2017 – 2021
Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 (USD million)
4.5 Country Segment Analysis 2017 – 2021
Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 (USD million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user – Market share 2022-2027 (%)
Exhibit 31: Data Table on End-user – Market share 2022-2027 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Academic research – Market size and forecast 2022-2027
Exhibit 34: Chart on Academic research – Market size and forecast 2022-2027 (USD million)
Exhibit 35: Data Table on Academic research – Market size and forecast 2022-2027 (USD million)
Exhibit 36: Chart on Academic research – Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Academic research – Year-over-year growth 2022-2027 (%)
6.4 Clinical research – Market size and forecast 2022-2027
Exhibit 38: Chart on Clinical research – Market size and forecast 2022-2027 (USD million)
Exhibit 39: Data Table on Clinical research – Market size and forecast 2022-2027 (USD million)
Exhibit 40: Chart on Clinical research – Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Clinical research – Year-over-year growth 2022-2027 (%)
6.5 Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027
Exhibit 42: Chart on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 (USD million)
Exhibit 43: Data Table on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 (USD million)
Exhibit 44: Chart on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
6.6 Others – Market size and forecast 2022-2027
Exhibit 46: Chart on Others – Market size and forecast 2022-2027 (USD million)
Exhibit 47: Data Table on Others – Market size and forecast 2022-2027 (USD million)
Exhibit 48: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others – Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by End-user
Exhibit 50: Market opportunity by End-user (USD million)
Exhibit 51: Data Table on Market opportunity by End-user (USD million)
7 Market Segmentation by Product
7.1 Market segments
Exhibit 52: Chart on Product – Market share 2022-2027 (%)
Exhibit 53: Data Table on Product – Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 54: Chart on Comparison by Product
Exhibit 55: Data Table on Comparison by Product
7.3 Consumables – Market size and forecast 2022-2027
Exhibit 56: Chart on Consumables – Market size and forecast 2022-2027 (USD million)
Exhibit 57: Data Table on Consumables – Market size and forecast 2022-2027 (USD million)
Exhibit 58: Chart on Consumables – Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Consumables – Year-over-year growth 2022-2027 (%)
7.4 Equipment – Market size and forecast 2022-2027
Exhibit 60: Chart on Equipment – Market size and forecast 2022-2027 (USD million)
Exhibit 61: Data Table on Equipment – Market size and forecast 2022-2027 (USD million)
Exhibit 62: Chart on Equipment – Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Equipment – Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Product
Exhibit 64: Market opportunity by Product (USD million)
Exhibit 65: Data Table on Market opportunity by Product (USD million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share by geography 2022-2027 (%)
Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America – Market size and forecast 2022-2027
Exhibit 71: Chart on North America – Market size and forecast 2022-2027 (USD million)
Exhibit 72: Data Table on North America – Market size and forecast 2022-2027 (USD million)
Exhibit 73: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America – Year-over-year growth 2022-2027 (%)
9.4 Europe – Market size and forecast 2022-2027
Exhibit 75: Chart on Europe – Market size and forecast 2022-2027 (USD million)
Exhibit 76: Data Table on Europe – Market size and forecast 2022-2027 (USD million)
Exhibit 77: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe – Year-over-year growth 2022-2027 (%)
9.5 Asia – Market size and forecast 2022-2027
Exhibit 79: Chart on Asia – Market size and forecast 2022-2027 (USD million)
Exhibit 80: Data Table on Asia – Market size and forecast 2022-2027 (USD million)
Exhibit 81: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia – Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) – Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 (USD million)
Exhibit 84: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 (USD million)
Exhibit 85: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
9.7 US – Market size and forecast 2022-2027
Exhibit 87: Chart on US – Market size and forecast 2022-2027 (USD million)
Exhibit 88: Data Table on US – Market size and forecast 2022-2027 (USD million)
Exhibit 89: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US – Year-over-year growth 2022-2027 (%)
9.8 Germany – Market size and forecast 2022-2027
Exhibit 91: Chart on Germany – Market size and forecast 2022-2027 (USD million)
Exhibit 92: Data Table on Germany – Market size and forecast 2022-2027 (USD million)
Exhibit 93: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany – Year-over-year growth 2022-2027 (%)
9.9 Canada – Market size and forecast 2022-2027
Exhibit 95: Chart on Canada – Market size and forecast 2022-2027 (USD million)
Exhibit 96: Data Table on Canada – Market size and forecast 2022-2027 (USD million)
Exhibit 97: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
9.10 China – Market size and forecast 2022-2027
Exhibit 99: Chart on China – Market size and forecast 2022-2027 (USD million)
Exhibit 100: Data Table on China – Market size and forecast 2022-2027 (USD million)
Exhibit 101: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on China – Year-over-year growth 2022-2027 (%)
9.11 UK – Market size and forecast 2022-2027
Exhibit 103: Chart on UK – Market size and forecast 2022-2027 (USD million)
Exhibit 104: Data Table on UK – Market size and forecast 2022-2027 (USD million)
Exhibit 105: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on UK – Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 107: Market opportunity by geography (USD million)
Exhibit 108: Data Tables on Market opportunity by geography (USD million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 10X Genomics Inc.
Exhibit 115: 10X Genomics Inc. – Overview
Exhibit 116: 10X Genomics Inc. – Product / Service
Exhibit 117: 10X Genomics Inc. – Key offerings
12.4 Azenta Inc.
Exhibit 118: Azenta Inc. – Overview
Exhibit 119: Azenta Inc. – Business segments
Exhibit 120: Azenta Inc. – Key offerings
Exhibit 121: Azenta Inc. – Segment focus
12.5 BGI Genomics Co. Ltd.
Exhibit 122: BGI Genomics Co. Ltd. – Overview
Exhibit 123: BGI Genomics Co. Ltd. – Product / Service
Exhibit 124: BGI Genomics Co. Ltd. – Key offerings
12.6 Bio Rad Laboratories Inc.
Exhibit 125: Bio Rad Laboratories Inc. – Overview
Exhibit 126: Bio Rad Laboratories Inc. – Business segments
Exhibit 127: Bio Rad Laboratories Inc. – Key news
Exhibit 128: Bio Rad Laboratories Inc. – Key offerings
Exhibit 129: Bio Rad Laboratories Inc. – Segment focus
12.7 Eurofins Scientific SE
Exhibit 130: Eurofins Scientific SE – Overview
Exhibit 131: Eurofins Scientific SE – Business segments
Exhibit 132: Eurofins Scientific SE – Key news
Exhibit 133: Eurofins Scientific SE – Key offerings
Exhibit 134: Eurofins Scientific SE – Segment focus
12.8 F. Hoffmann La Roche Ltd.
Exhibit 135: F. Hoffmann La Roche Ltd. – Overview
Exhibit 136: F. Hoffmann La Roche Ltd. – Business segments
Exhibit 137: F. Hoffmann La Roche Ltd. – Key news
Exhibit 138: F. Hoffmann La Roche Ltd. – Key offerings
Exhibit 139: F. Hoffmann La Roche Ltd. – Segment focus
12.9 Illumina Inc.
Exhibit 140: Illumina Inc. – Overview
Exhibit 141: Illumina Inc. – Business segments
Exhibit 142: Illumina Inc. – Key news
Exhibit 143: Illumina Inc. – Key offerings
Exhibit 144: Illumina Inc. – Segment focus
12.10 Konica Minolta Inc.
Exhibit 145: Konica Minolta Inc. – Overview
Exhibit 146: Konica Minolta Inc. – Business segments
Exhibit 147: Konica Minolta Inc. – Key news
Exhibit 148: Konica Minolta Inc. – Key offerings
Exhibit 149: Konica Minolta Inc. – Segment focus
12.11 Laboratory Corp. of America Holdings
Exhibit 150: Laboratory Corp. of America Holdings – Overview
Exhibit 151: Laboratory Corp. of America Holdings – Business segments
Exhibit 152: Laboratory Corp. of America Holdings – Key news
Exhibit 153: Laboratory Corp. of America Holdings – Key offerings
Exhibit 154: Laboratory Corp. of America Holdings – Segment focus
12.12 Merck KGaA
Exhibit 155: Merck KGaA – Overview
Exhibit 156: Merck KGaA – Business segments
Exhibit 157: Merck KGaA – Key news
Exhibit 158: Merck KGaA – Key offerings
Exhibit 159: Merck KGaA – Segment focus
12.13 Perkin Elmer Inc.
Exhibit 160: Perkin Elmer Inc. – Overview
Exhibit 161: Perkin Elmer Inc. – Business segments
Exhibit 162: Perkin Elmer Inc. – Key news
Exhibit 163: Perkin Elmer Inc. – Key offerings
Exhibit 164: Perkin Elmer Inc. – Segment focus
12.14 QIAGEN NV
Exhibit 165: QIAGEN NV – Overview
Exhibit 166: QIAGEN NV – Product / Service
Exhibit 167: QIAGEN NV – Key news
Exhibit 168: QIAGEN NV – Key offerings
12.15 Standard BioTools Inc.
Exhibit 169: Standard BioTools Inc. – Overview
Exhibit 170: Standard BioTools Inc. – Product / Service
Exhibit 171: Standard BioTools Inc. – Key news
Exhibit 172: Standard BioTools Inc. – Key offerings
12.16 Takara Bio Inc.
Exhibit 173: Takara Bio Inc. – Overview
Exhibit 174: Takara Bio Inc. – Business segments
Exhibit 175: Takara Bio Inc. – Key offerings
Exhibit 176: Takara Bio Inc. – Segment focus
12.17 Thermo Fisher Scientific Inc.
Exhibit 177: Thermo Fisher Scientific Inc. – Overview
Exhibit 178: Thermo Fisher Scientific Inc. – Business segments
Exhibit 179: Thermo Fisher Scientific Inc. – Key news
Exhibit 180: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 181: Thermo Fisher Scientific Inc. – Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 182: Inclusions checklist
Exhibit 183: Exclusions checklist
13.3 Currency conversion rates for USUSD
Exhibit 184: Currency conversion rates for USUSD
13.4 Research methodology
Exhibit 185: Research methodology
Exhibit 186: Validation techniques employed for market sizing
Exhibit 187: Information sources
13.5 List of abbreviations
Exhibit 188: List of abbreviations
About US
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com
SOURCE Technavio
